The renin–angiotensin system blockers and survival in digestive system malignancies: A systematic review and meta-analysis

BACKGROUND: Accumulating pre-clinical and clinical studies suggested that the renin–angiotensin system blockers (RASBs) possess anti-carcinogenic properties, and their use is associated with favorable outcomes in many types of cancers. METHODS: A systematic literature search of relevant databases th...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Qi, Chen, Di-Shi, Xin, Lin, Zhou, Li-Qiang, Zhang, Hou-Ting, Liu, Li, Yuan, Yi-Wu, Li, Shi-Hao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2020
Materias:
4500
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7035076/
https://www.ncbi.nlm.nih.gov/pubmed/32049809
http://dx.doi.org/10.1097/MD.0000000000019075

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7035076/
https://www.ncbi.nlm.nih.gov/pubmed/32049809
http://dx.doi.org/10.1097/MD.0000000000019075

Ejemplares similares